Structure of the Malaria Vaccine Candidate Pfs48/45 and Its Recognition by Transmission Blocking Antibodies
Overview
Authors
Affiliations
An effective malaria vaccine remains a global health priority and vaccine immunogens which prevent transmission of the parasite will have important roles in multi-component vaccines. One of the most promising candidates for inclusion in a transmission-blocking malaria vaccine is the gamete surface protein Pfs48/45, which is essential for development of the parasite in the mosquito midgut. Indeed, antibodies which bind Pfs48/45 can prevent transmission if ingested with the parasite as part of the mosquito bloodmeal. Here we present the structure of full-length Pfs48/45, showing its three domains to form a dynamic, planar, triangular arrangement. We reveal where transmission-blocking and non-blocking antibodies bind on Pfs48/45. Finally, we demonstrate that antibodies which bind across this molecule can be transmission-blocking. These studies will guide the development of future Pfs48/45-based vaccine immunogens.
Adeleke M Bioinform Biol Insights. 2025; 19:11779322241306215.
PMID: 40034580 PMC: 11873872. DOI: 10.1177/11779322241306215.
Bekkering E, Yoo R, Hailemariam S, Heide F, Ivanochko D, Jackman M bioRxiv. 2025; .
PMID: 39990443 PMC: 11844449. DOI: 10.1101/2025.02.14.638310.
Yoo R, Jore M, Julien J Immunol Rev. 2025; 330(1):e70001.
PMID: 39907429 PMC: 11796336. DOI: 10.1111/imr.70001.
Amen A, Yoo R, Fabra-Garcia A, Bolscher J, Stone W, Bally I Elife. 2025; 13.
PMID: 39817720 PMC: 11737873. DOI: 10.7554/eLife.97865.
Proceedings of the Conference "CMV Vaccine Development-How Close Are We?" (27-28 September 2023).
Schleiss M, Crooks C, Karthigeyan K, Kruc R, Otero C, Wang H Vaccines (Basel). 2024; 12(11).
PMID: 39591134 PMC: 11598149. DOI: 10.3390/vaccines12111231.